Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Board Changes

26 Mar 2013 16:19

RNS Number : 9352A
Plant Health Care PLC
26 March 2013
 



 

26 March 2013

 

Plant Health Care plc

("Plant Health Care" or "the Company")

Board Changes 

Plant Health Care plc, ("PHC"),a leading provider of novel patent protected biological products to the global agriculture markets, is today announcing the appointment of a new Chief Executive Officer, among other Board changes.

 

After twelve years as CEO of Plant Health Care, John Brady will be stepping down on 2 April 2013. He will be succeeded by Paul Schmidt who will take over as CEO the same day.

 

John has provided outstanding leadership of the Company and the Board would like to pay tribute to his enormous contribution. The Board is delighted that the Company is retaining John's services as a non-executive director, in which role the Company will continue to benefit from his invaluable experience.

 

The Company is pleased to welcome Paul Schmidt. Mr Schmidt has extensive operational experience in the agriculture industry, having served in senior roles in the USA, Germany and Canada during 25 years with Bayer CropScience and its predecessor companies. As President of Merck/EMD Crop Bioscience, a leading developer of natural plant health products, Paul led a turn-around which resulted in substantially increased sales and profit. In February 2011, he oversaw the sale of the business to Novozymes for $275 million. Paul graduated from the University of Saskatchewan with a BSA in Agronomy in 1980.

 

Sam Wauchope, having served as a non-executive director for nine years, four of them as Senior Independent Director, will step down from the Board on 2 April 2013. The Board would like to thank Sam for the contribution he has made to the Company.

 

Michael Higgins will join the Company as the Senior Independent Director and Chair of the Audit Committee following the Company's AGM on 9 May 2013. He is currently non-executive Chairman of AIM quoted Ebiquity plc and Deputy Chairman of the Quoted Companies Alliance. Michael also works with, and invests in, a number of early-stage businesses. Michael was a Senior Adviser at KPMG following ten years as a Partner. Prior to KPMG, he was a Director at Charterhouse Bank, worked at Saudi International Bank and qualified as an accountant with Price Waterhouse (now PricewaterhouseCoopers).

 

Dr. Christopher Richards, Chairman commented: "I wish to place on record our appreciation of all that John has done for Plant Health Care; this Company is very much his personal creation. I am delighted that we are retaining John's services as a non-executive director, in which role we will continue to benefit from his invaluable experience. I would also like to take this opportunity to pay tribute to Sam for his contribution, which included a stint as Interim Chairman in 2012.

 

"Securing the services of Paul Schmidt as the Company's new CEO is a real coup. Paul's extensive experience in the industry leaves us very well positioned to progress to the next stage in the Company's development. I am convinced that Paul has the right qualities to lead Plant Health Care to this next level. We look forward to welcoming Michael to the Company and to the Board following our AGM. Michael will bring a wealth of additional experience that we will benefit from."

 

 

- ENDS -

 

About Plant Health Care plc: Plant Health Care plc ("Plant Health Care") is a leading provider of novel patent protected biological products to the global agriculture markets. The Company's ordinary shares have been quoted on the AIM Market of the London Stock Exchange since July 2004 and listed on the Official List of the Channel Islands Stock Exchange ("CISX") since February 2010 (ticker symbol/mnemonic: PHC).

Further information is available at: www.planthealthcare.com.

 

 For further information, please contact:

Plant Health Care plc

 

 

Dr Christopher Richards, Chairman

On the day Tel: +44 (0) 20 7250 1446

John Brady, Chief Executive Officer

On the day Tel: +44 (0) 20 7250 1446

Thereafter: Tel: +1-603-525-3702 

Stephen Weaver, Finance Director

Tel: +1-412-826-5488 x151

 

Nomura Code Securities

Chris Collins / Clare Terlouw / Chris Golden

Tel: +44 (0) 20 7776 1200

Powerscourt

Paul Durman / Nick Dibden / Sophie Moate

Tel: +44 (0) 20 7250 1446

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAJFMFTMBBTBJJ
Date   Source Headline
2nd Jul 20242:23 pmRNSForm 8.3 - Plant Health Care plc
1st Jul 20249:46 amRNSForm 8.5 (EPT/NON-RI)
1st Jul 20247:32 amRNSForm 8.3 - Plant Health Care plc
28th Jun 20241:38 pmRNSForm 8.3 - Plant Health Care PLC
28th Jun 202411:35 amRNSForm 8.3 - Plant Health Care plc
28th Jun 202411:31 amRNSResult of GM & AGM
28th Jun 202410:13 amRNSForm 8.3 - Plant Health Care Plc
28th Jun 20249:16 amRNSForm 8.5 (EPT/NON-RI)
28th Jun 20248:59 amRNSForm 8.3 - Plant Health Care plc
27th Jun 20241:03 pmPRNForm 8.3 - Plant Health Care Plc
27th Jun 202412:13 pmRNSForm 8.3 - Plant Health Care plc
27th Jun 20249:43 amRNSForm 8.3 - Plant Health Care plc
27th Jun 20249:08 amRNSForm 8.5 (EPT/NON-RI)
26th Jun 20245:55 pmRNSForm 8.3 - Plant Health Care
26th Jun 20241:23 pmRNSRecommended Cash Acquisition of Plant Health Care
12th Jun 20245:22 pmRNSNotice of General Meeting
5th Jun 20245:09 pmRNSNotice of Annual General Meeting
4th Jun 20247:00 amRNSExpanded New California Label for Employ®
31st May 20245:05 pmRNSFull Year Results
16th May 20242:24 pmRNSHolding(s) in Company
14th May 20242:58 pmRNSHolding(s) in Company
8th May 20247:00 amRNSTrading Update
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.